Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder ...Middle East

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA Acquisition strengthens...

Hence then, the article about servier acquires potential treatment for fragile x syndrome the most common genetic cause of autism spectrum disorder was published today ( Monday 08/09/2025 - 10:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder )

Also on site :

• UN welcomes ceasefire announced by Ukraine, Russia
• Demi Moore Reveals How to Actually Pronounce Her Name
• Not to be dramatic, but LEGO Batman: Legacy of the Dark Knight might be the best Batman game ever